Consistent with this finding, a combination of apo-IDO-1 inhibitor with apatinib [68] or sodium tanshinone IIA sulfonate (IDO-1 inhibitor) with anti-PD1 therapy [69] has been shown to increase CD8 + T-cell infiltration in colorectal cancer. This evidence concerns the gene IDO1 and colorectal cancer.